What statement indicates a client's understanding of venlafaxine therapy?

The statement that indicates a client's understanding of venlafaxine therapy is that they may have increased thoughts of harming themselves. Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used primarily to treat depression and anxiety disorders. One important consideration when initiating or adjusting the dose of this medication is the potential for an increase in suicidal thoughts or behaviors, especially in the early stages of treatment or when doses are changed. This risk is particularly heightened in younger populations and those with a history of suicidal ideation.

While patients may experience benefits from the medication, it is crucial for them to be aware of this serious potential side effect. Regular follow-up with healthcare providers is important to monitor for any worsening of symptoms or emergence of suicidal thoughts, ensuring patient safety.

The other statements do not accurately reflect the nature of venlafaxine therapy. For instance, the expectation of feeling immediate improvement oversimplifies the therapeutic timeline of antidepressants, which typically takes several weeks to show significant effects. As for blood pressure, venlafaxine can actually cause dose-dependent increases in blood pressure, especially at higher doses. Lastly, while ongoing assessment is necessary, the frequency and nature of lab tests needed for venlafaxine therapy are not typically